Literature DB >> 27940223

MOPS and coxsackievirus B3 stability.

Steven D Carson1, Susan Hafenstein2, Hyunwook Lee3.   

Abstract

Study of coxsackievirus B3 strain 28 (CVB3/28) stability using MOPS to improve buffering in the experimental medium revealed that MOPS (3-morpholinopropane-1-sulfonic acid) increased CVB3 stability and the effect was concentration dependent. Over the pH range 7.0-7.5, virus stability was affected by both pH and MOPS concentration. Computer-simulated molecular docking showed that MOPS can occupy the hydrophobic pocket in capsid protein VP1 where the sulfonic acid head group can form ionic and hydrogen bonds with Arg95 and Asn211 near the pocket opening. The effects of MOPS and hydrogen ion concentrations on the rate of virus decay were modeled by including corresponding parameters in a recent kinetic model. These results indicate that MOPS can directly associate with CVB3 and stabilize the virus, possibly by altering capsid conformational dynamics.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Coxsackievirus; MOPS; Stability; pH

Mesh:

Substances:

Year:  2016        PMID: 27940223      PMCID: PMC5218500          DOI: 10.1016/j.virol.2016.12.002

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  37 in total

1.  Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment.

Authors:  Michaela Schmidtke; Elke Hammerschmidt; Susanne Schüler; Roland Zell; Eckhard Birch-Hirschfeld; Vadim A Makarov; Olga B Riabova; Peter Wutzler
Journal:  J Antimicrob Chemother       Date:  2005-09-08       Impact factor: 5.790

Review 2.  Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease.

Authors:  Patricia E Tam
Journal:  Viral Immunol       Date:  2006       Impact factor: 2.257

3.  Nectin-like interactions between poliovirus and its receptor trigger conformational changes associated with cell entry.

Authors:  Mike Strauss; David J Filman; David M Belnap; Naiqian Cheng; Roane T Noel; James M Hogle
Journal:  J Virol       Date:  2015-01-28       Impact factor: 5.103

4.  Crystal structure of human enterovirus 71.

Authors:  Pavel Plevka; Rushika Perera; Jane Cardosa; Richard J Kuhn; Michael G Rossmann
Journal:  Science       Date:  2012-03-01       Impact factor: 47.728

Review 5.  The group B coxsackieviruses and myocarditis.

Authors:  K S Kim; G Hufnagel; N M Chapman; S Tracy
Journal:  Rev Med Virol       Date:  2001 Nov-Dec       Impact factor: 6.989

6.  The crystal structure of indole-3-glycerol phosphate synthase from the hyperthermophilic archaeon Sulfolobus solfataricus in three different crystal forms: effects of ionic strength.

Authors:  T R Knöchel; M Hennig; A Merz; B Darimont; K Kirschner; J N Jansonius
Journal:  J Mol Biol       Date:  1996-10-04       Impact factor: 5.469

7.  Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor.

Authors:  Y He; P R Chipman; J Howitt; C M Bator; M A Whitt; T S Baker; R J Kuhn; C W Anderson; P Freimuth; M G Rossmann
Journal:  Nat Struct Biol       Date:  2001-10

8.  Inhibition of the uncoating of bovine enterovirus by short chain fatty acids.

Authors:  N Ismail-Cassim; C Chezzi; J F Newman
Journal:  J Gen Virol       Date:  1990-10       Impact factor: 3.891

9.  HeLa cell heterogeneity and coxsackievirus B3 cytopathic effect: implications for inter-laboratory reproducibility of results.

Authors:  Steven D Carson; Samuel J Pirruccello
Journal:  J Med Virol       Date:  2013-02-13       Impact factor: 2.327

10.  Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature.

Authors:  Q Li; A G Yafal; Y M Lee; J Hogle; M Chow
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

View more
  2 in total

1.  Albumin Enhances the Rate at Which Coxsackievirus B3 Strain 28 Converts to A-Particles.

Authors:  Steven D Carson; Andrew J Cole
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

2.  Mathematical modeling of plus-strand RNA virus replication to identify broad-spectrum antiviral treatment strategies.

Authors:  Carolin Zitzmann; Christopher Dächert; Bianca Schmid; Hilde van der Schaar; Martijn van Hemert; Alan S Perelson; Frank J M van Kuppeveld; Ralf Bartenschlager; Marco Binder; Lars Kaderali
Journal:  bioRxiv       Date:  2022-07-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.